首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >HIV-1-suppressive factors are secreted by CD4~+ T cells during primary immune responses
【24h】

HIV-1-suppressive factors are secreted by CD4~+ T cells during primary immune responses

机译:HIV-1抑制因子在初次免疫反应中由CD4〜+ T细胞分泌

获取原文
获取原文并翻译 | 示例
       

摘要

CD4~+ T cells are required for immunity against many viral infections, including HIV-1 where a positive correlation has been observed between strong recall responses and low HIV-1 viral loads. Some HIV-1-specific CD4~+ T cells are preferentially infected with HIV-1, whereas others escape infection by unknown mechanisms. One possibility is that some CD4~+ T cells are protected from infection by the secretion of soluble HIV-suppressive factors, although it is not known whether these factors are produced during primary antigen-specific responses. Here, we show that soluble suppressive factors are produced against CXCR4 and CCR5 isolates of HIV-1 during the primary immune response of human CD4~+ T cells. This activity requires antigenic stimulation of naieve CD4~+ T cells. One anti-CXCR4 factor is macrophage-derived chemokine (chemokine ligand 22, CCL22), and anti-CCR5 factors include mac-rophage inflammatory protein-1α (CCL3), macrophage inflammatory protein-1β (CCL4), and RANTES (regulated upon activation of normal T cells expressed and secreted) (CCL5). Intracellular staining confirms that CD3~+CD4~+ T cells are the source of the prototype HIV-1-inhibiting chemokines CCL22 and CCL4. These results show that CD4~+ T cells secrete an evolving HIV-1-suppressive activity during the primary immune response and that this activity is comprised primarily of CC chemokines. The data also suggest that production of such factors should be considered in the design of vaccines against HIV-1 and as a mechanism whereby the host can control infections with this virus.
机译:CD4 + T细胞是抵抗许多病毒感染(包括HIV-1)的免疫力所必需的,其中HIV-1在强召回反应和低HIV-1病毒载量之间呈正相关。一些HIV-1特异性CD4〜+ T细胞优先感染HIV-1,而另一些则通过未知机制逃脱感染。一种可能性是一些CD4 + T细胞受到可溶性HIV抑制因子的分泌的保护而不受感染,尽管尚不知道这些因子是否在原发性抗原特异性反应中产生。在这里,我们显示了在人类CD4〜+ T细胞的初次免疫应答过程中,针对HIV-1的CXCR4和CCR5分离株产生了可溶性抑制因子。该活性需要抗原刺激幼稚的CD4 + T细胞。一种抗CXCR4因子是巨噬细胞衍生的趋化因子(趋化因子配体22,CCL22),抗CCR5因子包括巨噬细胞炎性蛋白1α(CCL3),巨噬细胞炎性蛋白1β(CCL4)和RANTES(激活后调节)表达和分泌的正常T细胞数量(CCL5)。细胞内染色证实CD3〜+ CD4〜+ T细胞是抑制HIV-1的原始趋化因子CCL22和CCL4的来源。这些结果表明,CD4 + T细胞在初次免疫反应中分泌正在发展的HIV-1抑制活性,并且该活性主要由CC趋化因子组成。数据还表明,在设计针对HIV-1的疫苗时应考虑此类因素的产生,并作为宿主控制该病毒感染的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号